Co-chairs from the malERA Refresh Panels will discuss the findings of the updated malaria eradication research agenda (malERA) consultative process at the ASTMH annual meeting in Atlanta, USA. The symposium 'malERA Refresh: Updating the Malaria Eradication Scientific Agenda' is scheduled for Wednesday, 16 November, 1:45, Marriott Imperial B.
Several scientific papers have disappeared from internet.
For example the clinical trials with Artemisia annua in RD Congo from 2000 (attachment 1)
(M.S. Mueller , I.B. Karhagomba , H.M. Hirt , E. Wemakor. The potential of Artemisia annua L. as a locally produced remedy for malaria in the tropics: agricultural, chemical and clinical aspects. Journal of Ethnopharmacology 73 (2000) 487–493)
and clinical trials 2002 (attachment 2)
THE KELCH PROPELLER HYPOTHESIS
The WHO Global Malaria Programme is currently calling for applications for membership on the Technical Expert Group on Surveillance, Monitoring and Evaluation. A total of 13 experts will be selected for an initial term of up to three years.
The James Cook University, Australia has two vacancies:
- Head of Academic Group and Senior Lecturer/Associate Professor, Communicable Disease Control and Tropical Medicine
- Lecturer, Public Health and Tropical Medicine
Applications close: 13 November 2016
It was dicovered by a Yugoslav chemist called Milutin Stefanovic.
Proanthocyanidins (condensed tannins) are oligomeric and polymeric products of the flavonoid biosynthetic pathway. They are present in the fruits, bark, leaves and seeds of many plants, wine and teas, and are increasingly recognized as having beneficial effects on human health. They have attracted little interest in malaria research because in vitro they show no significant antimalarial activity.
Submitted by Jean-Jacques Schul
Founder of IDAY-International.
As a reaction to recent articles Financial Times
Malar J. 2016; 15: 419.
Published online 2016 Aug 18. doi: 10.1186/s12936-016-1470-8
Towards malaria elimination in the MOSASWA (Mozambique, South Africa and Swaziland) region
Devanand Moonasar, Rajendra Maharaj, Simon Kunene, Baltazar Candrinho, Francisco Saute, Nyasatu Ntshalintshali, and Natashia Morris corresponding author.
This infographic displays data from the World Health Organization’s “Projections of mortality and causes of death, 2015 and 2030”. The report details all deaths in 2015 by cause and makes predictions for 2030, giving an impression of how global health will develop over the next 14 years. Also featured is data from geoba.se showing how life expectancy will change between now and 2030.
SciDev.Net article - 21-09-2016
In a recent article about the spread of resistance to ACT in SE Asia, the authors recommend new drugs and better drug strategies:
'FEMS Microbiol Rev. 2016 Sep 8. pii: fuw037. [Epub ahead of print]
The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
Woodrow CJ1, White NJ2'.
Similarly, multiple resistance of Anopheline vectors is supposedly to be met with more careful selection of insecticides!
Allelopathy related to Artemisia plants has already been described 100 years ago (Bode, H. R. 1939. Über die Blattausscheidungen des Wermuts und ihre Wirkung auf andere Pflanzen. Planta 30:567-589). The work of H Bode was completed a few years later (GL Funke. Blumea - Biodiversity, Evolution and Biogeography of Plants, 1943 5, 281-293). Eighteen species of plants, most of which were chosen at random, were sown beside a hedge of Artemisia absinthium; they were severely injured and in one case even killed by the chemical excretions of the latter within a distance of ± 100 cm.
illumigene® Malaria, a novel, highly accurate test developed by Meridian Bioscience, has been awarded the coveted Journées Internationales de Biologie prize for Innovation in emergency treatment and point of care testing.
I am delighted to welcome Dr Fred Binka as Coordinator of WHO’s Emergency Response to Artemisinin Resistance (ERAR) hub in Phnom Penh, Cambodia.
Most of us ignore that on Nov 3, 2015 a Convention was signed in Bali declaring the fight against the looming TB-Diabetes co-epidemic, one of the greatest global health challenges.
An estimated two billion people, or one third of all people worldwide, live with a tuberculosis (TB) infection, of whom 9.6 million people develop active TB disease annually. TB is the leading cause of death worldwide due to a single infectious pathogen, responsible for 1.5 million human deaths in 2014, and 95 percent of human TB deaths occur in low- and middle-income countries.
It has traditionnally been accepted that drying of Artemisia annua should take place in the shade because drying in the sun would destroy many useful molecules. But recent papers have questionned this belief and have studied the effect of ultraviolet radiation on the accumulation or decrease of medicinal compounds in plants (WJ Zhang et al., Fitoterapia, 2009, 80, 207-18). A study in Turkey showed that UV-C radiation had remarkable promoting effects on the accumulation of secondary metabolites in the calli of a grape cultivar (E Cetin, Biological Research, 2014, 47 :37).
Plasmodium is thriving on iron. One of the first mistakes of Western medicine in Africa was the iron supplementation to the Somali nomads in 1968. Blood analysis of these nomads had shown that according to European standards they were suffering from anemia (MJ Murray et al., Brit Med J. Oct 1978, 1113-1116). But iron administration was associated with a significant increase of the disease it was supposed to suppress and even to reactivation of pre-existing diseases. The conclusion of the authors was that iron deficiency eventually plays a part in suppressing certain infections
There is dangerous obstacle - we call it the Immunity Trap - in malaria prevention strategies which is most dangerous for countries which have relied on the ephemeral methods recommended by WHO and used by PMI, but which have not included permanent methods. In the 19 African countries in the US Presidential Malaria Initiative administered by the PMI for the last decade, of the 30 million who have lost their immunity, about half are also no longer protected by house spraying because of the high cost of new biocides.
In a pionneering study in 2010, the University of Louvain had studied the anti-inflammatory effect and modulation of cytochrome P450 activities by Artemisia annua tea infusions in human intestinal Caco-2 cells (Melillo de Magalhães P1, et al.,. Food Chem. 2012 Sep 15;134.:864-71). These assays were done on aqueous infusions (3.3/L) of Artemisia annua samples from 7 different origins.
A decade ago, I helped the US Presidential Malaria Initiative get its start in Angola. Since then the Malaria Initiative (the US PMI) has expanded under Tim Ziemer to 19 African countries, protecting 30 million people. Consequently, over the last decade these 30 million people have lost their immunity to malaria. Now that might seem obvious and maybe a good thing. But since they live in regions where malaria is endemic, it raises a serious issue about durability of the PMI strategy.
The Resistance Treadmill
WHO recently released a report on the fight against malaria, by Cibulskis et al *. It seems very positive, in fact they claim that the progress is "remarkable". but I find two ironic aspects which are troubling.
Dear Partners and Friends,
After a period of extensive consultation, the RBM Board agreed at its 29th Meeting in December 2015 on a new governance architecture. This included the establishment of a reconstituted Partnership Board, which could take advantage of the tremendous skill, energy and effectiveness of its partners and lead the organization into a new era.
Would you like to hear some Good News? Here are some nuggets, stimulated partly by recent comments from my colleagues Robert Bos, Tony Kiszewski and Pierre Bush.
Classic Problems we used to face